Elevated Blood Pressure
Rising systolic and diastolic pressure strain arteries and the heart over time.
When Metabolic Balance Slips, Everything Suffers
Metabolic health is the quiet engine of your wellbeing. When it runs smoothly, energy is steady, mood is balanced, and your body uses fuel efficiently. But chronic stress, poor sleep, processed diets, and sedentary habits push the system out of balance, and the warning signs rarely stay in one place. They show up everywhere, long before they show up on the scale.
Insulin Resistance
Cells stop responding to insulin, pushing fasting glucose steadily higher.
Fatty Liver
Excess fat accumulates in liver cells, fueling inflammation and NAFLD.
Stubborn Belly Fat
Visceral fat releases inflammatory signals that disrupt the entire metabolic system.
Oxidized LDL
Damaged LDL particles drive arterial plaque and cardiovascular strain.
Mitochondrial Slowdown
Reduced oxygen utilization leaves you tired, foggy, and slow to recover.
Not Just Another Metabolic Support. A Clinically Proven One.
ThymoQuin is a standardized, cold-pressed, full-spectrum black seed oil (Nigella sativa), not an extract. It's produced from a non-GMO variety naturally bred to yield higher thymoquinone content, and it's the only black seed oil that meets USP monograph standards for strength, purity, and quality. What makes ThymoQuin different for metabolic health is the breadth of its action: thymoquinone influences the vascular, hepatic, lipid, and mitochondrial pathways at once, supporting whole-system balance rather than a single endpoint.
-
Lowers Blood Pressure
Clinically shown to reduce systolic BP by 11.2% and diastolic by 12.2% in 6 weeks.
-
Protects Liver & Lipids
Published research shows reduced LDL, oxidized LDL, hepatic fat, and liver fibrosis.
-
Powers Mitochondria
Boosts oxygen consumption, mitochondrial biogenesis, and HO-1 antioxidant activity.
Backed by Real Clinical Research. Not Just Claims.
A nonrandomized clinical trial conducted at Natural Medicine of Stillwater evaluated ThymoQuin® (500 mg/day, delivering 15 mg thymoquinone) in 20 adults over a 42-day treatment period. Daily blood pressure monitoring revealed significant reductions in both systolic and diastolic pressure, with initial effects measurable within just 48 hours of supplementation. After a washout and placebo crossover, blood pressure trended back toward baseline, confirming the effect was driven by ThymoQuin itself.
− 11.2%
Systolic BP
Reduction from 143.5 to 127.3 mm Hg over 6 weeks of daily use.
− 12.2%
Diastolic BP
Reduction from 90.7 to 79.6 mm Hg over 6 weeks of daily use.
48 hrs
Rapid Onset
Significant BP decline measured within two days of dosing.
120 / 80
Normalized BP
Average BP normalized from 140/90 in subjects off medication.
PRECLINICAL RESEARCH ON METABOLIC FUNCTION & FATTY LIVER
A peer-reviewed study published in the Journal of Nutrition & Food Sciences evaluated cold-pressed black seed oil standardized to 3% thymoquinone (TriNutra) in a murine model of diet-induced obesity. Over 8 weeks of supplementation in mice fed a high-fat diet, researchers documented improvements across multiple metabolic markers, including glucose, lipids, hepatic fat, and mitochondrial function, without any change in body weight, suggesting an effect on metabolic quality rather than caloric balance.
Fasting Glucose
Statistically significant reduction in fasting glucose vs. high-fat controls.
Hepatic Steatosis
Reduced liver fat, droplet diameter, and fibrosis, protecting against NAFLD.
Oxidized LDL
Significant decrease in LDL and oxidized LDL, key drivers of metabolic risk.
Mitochondria
Increased oxygen use, fusion proteins (Mfn1, Mfn2, OPA1), and HO-1 activity.
Composition and Quality Make the Difference
Not all black seed oils are created equal. Most products on the market contain less than 1% thymoquinone with high free fatty acid levels, meaning lower potency, poor stability, and inconsistent results. Some competitors claim 5–10% TQ, but research shows this can actually harm the beneficial gut bacteria the ingredient is supposed to support.
| PARAMETER | ThymoQuin® | Generic BSO |
|---|---|---|
| Thymoquinone (TQ) | ≥3% (standardized) | <1% (variable) |
| p-Cymene | >1% (controlled) | Uncontrolled (variable) |
| Free Fatty Acids | ≤1.25% | 7–50% |
| USP Monograph | Meets all standards | Does not meet |
| Clinical Validation | Double-blind, placebo-controlled | No clinical trials |
Looking for a Clinically Proven Metabolic Health Ingredient?
Our team can help you understand how ThymoQuin fits into your metabolic health, cardiovascular, or lipid-support formulation, from clinical data to dosing guidance to regulatory support.
Dr. Shawn Talbott on Cortisol
*These statements have not been evaluated by the FDA. ThymoQuin is not intended to diagnose, treat, cure, or prevent any disease. Always consult your healthcare provider before starting a new supplement.
